immunology The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to conduct pre-clinical tests and the challenges spin-off initiatives face today in Mexico. In the past pharmaceutical R&D activities…
See our Cookie Privacy Policy Here